| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
37,951,000 |
| Market
Cap: |
379.51(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$8.03 - $13.46 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 11.1 |
| Insider 6 Months : 11.1 |
| Insider 3/6 Months : 22.4 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile AgeX Therapeutics is a biotechnology company focused on the development and commercialization of therapeutics targeting human aging and degenerative diseases. Co.'s proprietary technology, based on telomerase-mediated cellular immortality and regenerative biology, allows it to utilize telomerase-expressing regenerative pluripotent stem cell (PSC) for the manufacture of cell-based therapies to regenerate tissues afflicted with age-related chronic degenerative disease. Co.'s product candidates in the discovery stage include two cell-based therapies derived from telomerase-positive PSCs and two product candidates derived from its proprietary induced Tissue Regeneration technology.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
32,586 |
32,586 |
32,586 |
32,586 |
| Total Buy Value |
$312,736 |
$312,736 |
$312,736 |
$312,736 |
| Total People Bought |
2 |
2 |
2 |
2 |
| Total Buy Transactions |
10 |
10 |
10 |
10 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Bailey Gregory |
Director |
– • – |
2024-05-30 |
4 |
B |
$9.50 |
$49,448 |
D/D |
5,205 |
20,206 |
2.39 |
3% |
|
| Bailey Gregory |
Director |
– • – |
2024-05-29 |
4 |
B |
$9.50 |
$11,144 |
D/D |
1,173 |
15,001 |
2.39 |
3% |
|
| Bailey Gregory |
Director |
– • – |
2024-05-28 |
4 |
B |
$9.50 |
$85,681 |
D/D |
9,019 |
13,828 |
2.39 |
2% |
|
| Bailey Gregory |
Director |
– • – |
2024-05-23 |
4 |
B |
$9.50 |
$22,525 |
D/D |
2,371 |
4,809 |
2.39 |
3% |
|
| Bailey Gregory |
Director |
– • – |
2024-05-21 |
4 |
B |
$9.50 |
$8,702 |
D/D |
916 |
2,438 |
2.39 |
-1% |
|
| Bailey Gregory |
Director |
– • – |
2024-05-21 |
4 |
B |
$9.50 |
$13,509 |
D/D |
1,422 |
1,522 |
2.39 |
-1% |
|
| Mintz Steven |
Director |
– • – |
2024-05-21 |
4 |
B |
$9.75 |
$90,885 |
I/I |
9,151 |
9,900 |
2.1 |
-1% |
|
| Bailey Gregory |
Director |
– • – |
2024-05-20 |
4 |
B |
$9.00 |
$900 |
D/D |
100 |
100 |
2.31 |
-3% |
|
| Mintz Steven |
Director |
– • – |
2024-05-20 |
4 |
B |
$9.42 |
$25,233 |
I/I |
2,675 |
1,240 |
2.1 |
-3% |
|
| Mintz Steven |
Director |
– • – |
2024-05-17 |
4 |
B |
$8.50 |
$4,709 |
I/I |
554 |
554 |
2.1 |
15% |
|
| Ledger Steven A |
Interim CEOOfficer |
• • – |
2024-03-26 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
227,927 |
|
- |
|
| Viegas Tacey |
COO and SecretaryOfficer |
• – – |
2024-03-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
58,610 |
|
- |
|
| Mintz Steven |
Director |
– • – |
2024-01-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
116,324 |
|
- |
|
| Juvenescence Us Corp. |
Director |
– • • |
2023-03-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
16,447,500 |
|
- |
|
| Juvenescence Ltd |
Director |
– • • |
2023-03-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
16,447,500 |
0 |
|
- |
|
| West Michael D |
Chief Executive Officer |
• – – |
2023-03-11 |
4 |
D |
$0.59 |
$625 |
D/D |
(1,060) |
41,982 |
|
- |
|
| West Michael D |
Chief Executive Officer |
• – – |
2023-03-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,125 |
43,042 |
|
- |
|
| West Michael D |
Chief Executive Officer |
• • – |
2022-12-11 |
4 |
D |
$0.59 |
$638 |
D/D |
(1,081) |
39,917 |
|
- |
|
| West Michael D |
Chief Executive Officer |
• • – |
2022-12-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,125 |
40,998 |
|
- |
|
| West Michael D |
Chief Executive Officer |
• • – |
2022-09-11 |
4 |
D |
$0.56 |
$608 |
D/D |
(1,081) |
44,503 |
|
- |
|
| West Michael D |
Chief Executive Officer |
• • – |
2022-09-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,125 |
45,584 |
|
- |
|
| West Michael D |
Chief Executive Officer |
• • – |
2022-03-11 |
4 |
D |
$0.69 |
$887 |
D/D |
(1,281) |
40,415 |
|
- |
|
| West Michael D |
Chief Executive Officer |
• • – |
2022-03-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,125 |
41,696 |
|
- |
|
| West Michael D |
Chief Executive Officer |
• • – |
2021-12-11 |
4 |
D |
$0.64 |
$686 |
D/D |
(1,081) |
38,571 |
|
- |
|
| West Michael D |
Chief Executive Officer |
• • – |
2021-12-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,125 |
39,652 |
|
- |
|
43 Records found
|
|
Page 1 of 2 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.25 (2.56%) 
